Buchler GmbH
  • Products
    • Active Pharmaceutical Ingredients
    • Asymmetric Synthesis
      • Chiral Building Blocks
      • Chiral Phase Transfer Catalysts (PTCs)
      • Chiral Screening Kit
      • Enantioselective Organocatalysts
      • Racemic Resolution
    • Food Ingredients
    • Product Overview
  • Chiral Catalyst Search (NEW)
  • Contact
  • About
    • Certificates
    • Company Policy
    • Former Buchler Company Managers
    • Galleries
      • Gallery current production and storage
      • Gallery Laboratory
      • Gallery Historical Production
    • History of Buchler
  • Career
Select Page

Trifluoromethylation, (E)-1-(3-bromophenyl)-3-phenylbut-3-en-1-one oxime, (S)-3-(3-bromophenyl)-5-phenyl-5-(2,2,2-trifluoroethyl)-4,5-dihydroisoxazole, copper acetate, N-[(9R)-10,11-dihydrocinchonan-9-yl]-2,3,4,5,6-pentamethyl-benzenesulfonamide, Dihydrocinchonine Derivative

by werner@buchler-gmbh.com | Mar 21, 2025

Thioalkylation, substituted 2-phenyl-2,3-dihydronaphthalene-1,4-dione, substituted benzenethiol, substituted 2-phenyl-3-(phenylthio)-2,3-dihydronaphthalene-1,4-dione, N-[(8α,9S)-6′-methoxycinchonan-9-yl]-2,4,6-trimethyl-benzamide, Quinine Derivative

by werner@buchler-gmbh.com | May 17, 2024

Hydrogenation of alpha-Ketoeste, methyl 2-(4-halogenophenyl)-2-oxoacetate, methyl (S)-2-(4-halogenophenyl)-2-hydroxyacetate, platinum/aluminiumoxide, Dihydrocinchonidine Base

by werner@buchler-gmbh.com | Feb 28, 2023

Hydrogenation of alpha-ketoester, alpha-ketoester, hydrogen, alpha-hydroxyester, platinum/aluminiumoxide, Cinchonidine Base

by Anna-Lena Hartmann | Sep 30, 2022

Glossary

Impressum / Legal Notice

Code of Conduct

Hinweisgebersystem / Whistleblowing System

Allgemeine Geschäfts-bedingungen / General Terms and Conditions

Datenschutzhinweise / Data Protection Information

Contact

My Account
  • Follow
  • Follow

All Rights Reserved by Buchler GmbH